Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
VTGN
VTGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VTGN News
Vistagen Faces Class Action Lawsuit; Investors Urged to Act
5h ago
Globenewswire
Vistagen Lawsuit Reminder for Investors
1d ago
Globenewswire
Vistagen Faces Class Action Lawsuit Amid 80% Stock Plunge
1d ago
Globenewswire
Vistagen Therapeutics Shareholder Notice Issued
1d ago
PRnewswire
Vistagen Lawsuit Reminder for Investors
4d ago
Globenewswire
Helus Pharma's HLP004 Phase 2 Study Results Disappoint
6d ago
Benzinga
Vistagen Therapeutics Faces Class Action Lawsuit
6d ago
Globenewswire
Vistagen Therapeutics Class Action Notice
6d ago
PRnewswire
Notice of Class Action Lawsuit Against Vistagen Therapeutics
6d ago
Globenewswire
Class Action Filed Against Vistagen for Investor Losses
Mar 05 2026
Globenewswire
Vistagen Investors Urged to Discuss Legal Rights Amid Significant Losses
Mar 04 2026
PRnewswire
Vistagen Therapeutics Investor Claim Notice
Mar 04 2026
PRnewswire
Vistagen Faces Class Action Lawsuit Impacting Stock Price
Mar 03 2026
Globenewswire
Faruqi & Faruqi Investigates Vistagen Securities Fraud Claims
Mar 03 2026
Globenewswire
Vistagen Therapeutics Faces Class Action for Securities Fraud
Mar 02 2026
Globenewswire
Vistagen Lawsuit Reminder for Investors
Mar 02 2026
Globenewswire
Show More News
